# Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.

> **NCT03196843** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital of Dalian Medical University** · enrollment: 202 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Raltitrexed
- **RADIATION:** Intensity Modulated Radiotherapy

## Key facts

- **NCT ID:** NCT03196843
- **Lead sponsor:** The First Affiliated Hospital of Dalian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-01
- **Primary completion:** 2020-08
- **Final completion:** 2023-08
- **Target enrollment:** 202 (ESTIMATED)
- **Last updated:** 2020-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03196843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03196843, "Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03196843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*